Shingo Takano1, Akira Matsumura. Show Affiliations » 1. Department of Neurosurgery, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki 305-8575, Japan. shingo4@md.tsukuba.ac.jp
Abstract
Entities: Disease
Mesh： See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabBrain Neoplasms/blood supplyBrain Neoplasms/drug therapyBrain Neoplasms/metabolismGenetic TherapyGlioma/blood supplyGlioma/drug therapyGlioma/metabolismHumansHypoxia-Inducible Factor 1, alpha Subunit/physiologyMedical Oncology/trendsNeovascularization, Pathologic/drug therapySignal TransductionVascular Endothelial Growth Factor A/physiology
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor ABevacizumab
Year: 2006 PMID： 16841703
Source DB: PubMed Journal: No Shinkei Geka ISSN： 0301-2603